These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7874883)

  • 61. Antimicrobial activity of imipenem and SCH34343 against Legionella species.
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1987 Apr; 6(4):307-9. PubMed ID: 3472705
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of quinolones and other antimicrobial agents on cell-associated Legionella pneumophila.
    Havlichek D; Saravolatz L; Pohlod D
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1529-34. PubMed ID: 3435101
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficacy of moxifloxacin, trovafloxacin, clinafloxacin and levofloxacin against intracellular Legionella pneumophila.
    Jonas D; Engels I; Friedhoff C; Spitzmüller B; Daschner FD; Frank U
    J Antimicrob Chemother; 2001 Feb; 47(2):147-52. PubMed ID: 11157897
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study.
    Joly-Guillou ML; Kempf M; Cavallo JD; Chomarat M; Dubreuil L; Maugein J; Muller-Serieys C; Roussel-Delvallez M
    BMC Infect Dis; 2010 Mar; 10():72. PubMed ID: 20298555
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Multicentre in-vitro evaluation of the susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to ciprofloxacin, clarithromycin, co-amoxiclav and sparfloxacin.
    Hoogkamp-Korstanje JA; Dirks-Go SI; Kabel P; Manson WL; Stobberingh EE; Vreede RW; Davies BI
    J Antimicrob Chemother; 1997 Mar; 39(3):411-4. PubMed ID: 9096192
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Determination of the activity on Legionella of eight macrolides and related agents by comparative testing on three media.
    Bornstein N; Roudier C; Fleurette J
    J Antimicrob Chemother; 1985 Jan; 15(1):17-22. PubMed ID: 3972756
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In vitro activity of sparfloxacin (CI-978), a new broad-spectrum fluoroquinolone.
    Qadri SM; Ueno Y; Burns JJ; Almodovar E; Rabea N
    Chemotherapy; 1992; 38(2):99-106. PubMed ID: 1317282
    [TBL] [Abstract][Full Text] [Related]  

  • 68. High-Throughput Intracellular Antimicrobial Susceptibility Testing of Legionella pneumophila.
    Chiaraviglio L; Kirby JE
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7517-29. PubMed ID: 26392509
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bactericidal activity of imipenem compared to erythromycin against intracellular Legionella pneumophila.
    Ramirez JA; Summersgill JT; Miller RD; Meyers TL; Raff MJ
    Drugs Exp Clin Res; 1992; 18(10):407-10. PubMed ID: 1306151
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lack of resistance to erythromycin, rifampicin and ciprofloxacin in 98 clinical isolates of Legionella pneumophila.
    Onody C; Matsiota-Bernard P; Nauciel C
    J Antimicrob Chemother; 1997 Jun; 39(6):815-6. PubMed ID: 9222053
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Methods for testing the susceptibility of anaerobic bacteria to two fluoroquinolone compounds, PD 131628 and clinafloxacin.
    Barry AL; Fuchs PC; Citron DM; Allen SD; Wexler HM
    J Antimicrob Chemother; 1993 Jun; 31(6):893-900. PubMed ID: 8395494
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [In vitro activity of sparfloxacin against methicillin-resistant staphylococci].
    Wallrauch C; Voss A; Milatovic D; Braveny I
    Arzneimittelforschung; 1995 Jun; 45(6):723-5. PubMed ID: 7646580
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Calcium-supplemented daptomycin Etest strips for susceptibility testing on Iso-Sensitest agar.
    Johnson AP; Mushtaq S; Warner M; Livermore DM
    J Antimicrob Chemother; 2004 May; 53(5):860-2. PubMed ID: 15056637
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Susceptibility of Legionella pneumophila to twenty antimicrobial agents.
    Edelstein PH; Meyer RD
    Antimicrob Agents Chemother; 1980 Sep; 18(3):403-8. PubMed ID: 7425611
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antimicrobial susceptibility profiles and tentative epidemiological cutoff values of
    Yang JL; Sun H; Zhou X; Yang M; Zhan XY
    Front Microbiol; 2022; 13():924709. PubMed ID: 36312931
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Increased recovery of Legionella micdadei and Legionella bozemanii on buffered charcoal yeast extract agar supplemented with albumin.
    Morrill WE; Barbaree JM; Fields BS; Sanden GN; Martin WT
    J Clin Microbiol; 1990 Mar; 28(3):616-8. PubMed ID: 2324282
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of GVPC and BCYE Media for
    Scaturro M; Poznanski E; Mupo M; Blasior P; Seeber M; Prast AM; Romanin E; Girolamo A; Rota MC; Bella A; Ricci ML; Stenico A
    Pathogens; 2020 Sep; 9(9):. PubMed ID: 32948082
    [No Abstract]   [Full Text] [Related]  

  • 78. Growth and phenotypic characterization of Legionella species on semisolid media made with washed agar.
    Rogers JE; Jones GW; Engleberg NC
    J Clin Microbiol; 1993 Jan; 31(1):149-51. PubMed ID: 8417021
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Culturing, media, and handling of legionella.
    Chatfield CH; Cianciotto NP
    Methods Mol Biol; 2013; 954():151-62. PubMed ID: 23150393
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparison of different agars used in the formulation of buffered charcoal yeast extract medium.
    Edelstein PH; Edelstein MA
    J Clin Microbiol; 1991 Jan; 29(1):190-1. PubMed ID: 1993756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.